Medicare Enrolled

Dr. Mukhtair Kundi, MD

Neurology · West Covina, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1740 W CAMERON AVE, West Covina, CA 91790
6269601402
In practice since 2006 (19 years)
NPI: 1821158775 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kundi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kundi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kundi

Dr. Mukhtair Kundi is a neurology specialist in West Covina, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kundi performed 4,537 Medicare services across 1,258 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kundi received a total of $6,841 from 51 pharmaceutical and/or device companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kundi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 15% volume in CA $6,841 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,537
Medicare services
Top 15% in CA for neurology
1,258
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~239 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
3,052 $66 $120
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
489 $99 $165
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
213 $132 $255
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
163 $86 $150
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
140 $145 $265
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
125 $350 $550
Additional hour of neuropsychological test evaluation
This code covers the evaluation of neuropsychological testing for each additional hour beyond the initial service. It represents the time spent analyzing and interpreting test results.
96 $84 $175
Psychological test administration, each additional 30 minutes
A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time.
96 $32 $65
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
80 $253 $1,300
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
32 $110 $173
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
32 $31 $65
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
19 $128 $245
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,841
Total received (2018-2024)
Avg $977/year across 7 years
Top 28% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
352
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,641 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$200 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,743
2023
$1,554
2022
$1,515
2021
$479
2020
$357
2019
$931
2018
$262

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$525
UCB, Inc.
$272
PFIZER INC.
$229
Alexion Pharmaceuticals, Inc.
$197
Eisai Inc.
$101
Lilly USA, LLC
$87
Teva Pharmaceuticals USA, Inc.
$58
Aucta Pharmaceuticals, Inc.
$33
MITSUBISHI TANABE PHARMA AMERICA, INC.
$33
Sumitomo Pharma America, Inc.
$27
Takeda Pharmaceuticals U.S.A., Inc.
$27
Amylyx Pharmaceuticals, Inc.
$26
Celgene Corporation
$25
Amneal Pharmaceuticals LLC
$23
Kyowa Kirin, Inc.
$23
ARGENX US, INC.
$22
Novartis Pharmaceuticals Corporation
$19
Lundbeck LLC
$18
Top 3 companies account for 58.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,316
Alexion Pharmaceuticals, Inc.
$529
UCB, Inc.
$516
PFIZER INC.
$364
ARGENX US, INC.
$355
Lilly USA, LLC
$316
Teva Pharmaceuticals USA, Inc.
$312
Sunovion Pharmaceuticals Inc.
$291
Biohaven Pharmaceutical Holding Company Ltd.
$290
ACADIA Pharmaceuticals Inc
$218
Amneal Pharmaceuticals LLC
$196
Kyowa Kirin, Inc.
$163
Amgen Inc.
$147
Novartis Pharmaceuticals Corporation
$134
Neurocrine Biosciences, Inc.
$113
Allergan, Inc.
$101
Eisai Inc.
$101
Philips Electronics North America Corporation
$89
AbbVie Inc.
$87
MITSUBISHI TANABE PHARMA AMERICA, INC.
$71
Akcea Therapeutics, Inc.
$68
Abbott Laboratories
$67
Biogen, Inc.
$65
Lundbeck LLC
$64
AstraZeneca Pharmaceuticals LP
$63
Biohaven Pharmaceuticals, Inc.
$59
Sumitomo Pharma America, Inc.
$55
LivaNova USA, Inc.
$52
Corium, LLC
$49
Neurelis, Inc.
$47
Bard Peripheral Vascular, Inc.
$47
Supernus Pharmaceuticals, Inc.
$45
Catalyst Pharmaceuticals, Inc.
$40
Mitsubishi Tanabe Pharma America, Inc.
$37
Aucta Pharmaceuticals, Inc.
$33
EMD Serono, Inc.
$32
MDD US Operations, LLC
$31
Takeda Pharmaceuticals U.S.A., Inc.
$27
ARBOR PHARMACEUTICALS, INC.
$27
Amylyx Pharmaceuticals, Inc.
$26
CATALYST PHARMACEUTICALS, INC.
$25
Celgene Corporation
$25
Avanir Pharmaceuticals, Inc.
$24
CSL Behring
$22
Adamas Pharmaceuticals, Inc.
$22
Vertical Pharmaceuticals, LLC
$20
Acorda Therapeutics, Inc
$19
Vertiflex, Inc.
$19
AbbVie, Inc.
$15
Retrophin, Inc.
$5
Travere Therapeutics, Inc.
$1
Top 3 companies account for 34.5% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ADLARITY · ADUHELM · AIMOVIG · AMYVID · APTIOM · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · BRILINTA · Briviact · COMIRNATY · Cholbam · DUOPA · Duopa · EMGALITY · FIRDAPSE · GILENYA · GOCOVRI · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · Leqembi · MAYZENT · Motpoly XR · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OSMOLEX ER · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · QULIPTA · RADICAVA · RELYVRIO · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · Soliris · Superion ISS · TECFIDERA · TEGSEDI · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VYEPTI · VYVGART · ZEPOSIA · Zilbrysq · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in West Covina?
Compare neurologists in the West Covina area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
412
Per 100K population
4.2
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - BALDWIN PARK
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kundi is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kundi experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Kundi performed 3,052 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kundi receive payments from pharmaceutical companies?
Yes. Dr. Kundi received a total of $6,841 from 51 companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kundi's costs compare to other neurologists in West Covina?
Dr. Kundi's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kundi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →